Jennifer Sargent
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jennifer Sargent has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ajay Kumar Mishra
Department of Cardiology, Concord Hospital, Concord, NH 03301, USA
9 shared publications - Amos Lal
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
6 shared publications - Kamal Kant Sahu
Department of Internal Medicine, Huntsman Cancer Institute, University of Utah
5 shared publications Kamal Kant Sahu
Department of Internal Medicine, Saint Vincent Hospital, Worcester, Mass
3 shared publicationsAnu Anna George
Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA
2 shared publications- Anu Anna George
Department of Dermatology, Christian Medical College, Vellore, India
2 shared publications
Latest Publications
- Open Access
- 11 May 2022
- Vol. 93 (2) , e2022203
Predictors, patterns and outcomes following Infective endocarditis and stroke.
Patients with infective endocarditis can have multiple neurological manifestations. Cerebrovascular events (CVE) in patients with IE can be hemorrhagic or embolic. Multiple factors are known to predispose to CVE and increased mortality in patients with IE. In this study, we aimed to describe various outcomes among patients with IE and CVE. We retrospectively analyzed 160 patients with definite IE. Among these, patients with radiological evidence of CVE were included. Clinical, radiological, echocardiographic details were obtained. Outcome studied were the requirement of intensive care unit care, the requirement of mechanical ventilation, prolonged course of antibiotics, prolonged duration of hospital stay, the requirement of surgical intervention, and mortality. In this study, 16 [10%] of patients with IE were identified to have a CVE. The mean age of the patients was 55, and 87.5% of them were male. 25% of patients had prior IE. IE involving left-sided valves were predominant, with the involvement of mitral valve reported in 62.5% of patients. More than half of the patient's had details of magnetic resonance imaging (MRI) of the brain. CVE were mostly ischemic, anterior circulation predominant, multiple, and bilateral. In patients with IE and CVE morbidity including the requirement of ICU care, prolonged antibiotics course, and the requirement of surgical intervention contributed to increased duration of hospital stay. In conclusion, CVE in patients with IE tends to present as multiple infarcts predominantly located over anterior circulation. IE patients with CVE tend to have higher morbidity and mortality.
- 11 May 2022
- Vol. 93 (2) , e2022203
Open AccessPredictors, patterns and outcomes following Infective endocarditis and stroke.
Patients with infective endocarditis can have multiple neurological manifestations. Cerebrovascular events (CVE) in patients with IE can be hemorrhagic or embolic. Multiple factors are known to predispose to CVE and increased mortality in patients with IE. In this study, we aimed to describe various outcomes among patients with IE and CVE. We retrospectively analyzed 160 patients with definite IE. Among these, patients with radiological evidence of CVE were included. Clinical, radiological, echocardiographic details were obtained. Outcome studied were the requirement of intensive care unit care, the requirement of mechanical ventilation, prolonged course of antibiotics, prolonged duration of hospital stay, the requirement of surgical intervention, and mortality. In this study, 16 [10%] of patients with IE were identified to have a CVE. The mean age of the patients was 55, and 87.5% of them were male. 25% of patients had prior IE. IE involving left-sided valves were predominant, with the involvement of mitral valve reported in 62.5% of patients. More than half of the patient's had details of magnetic resonance imaging (MRI) of the brain. CVE were mostly ischemic, anterior circulation predominant, multiple, and bilateral. In patients with IE and CVE morbidity including the requirement of ICU care, prolonged antibiotics course, and the requirement of surgical intervention contributed to increased duration of hospital stay. In conclusion, CVE in patients with IE tends to present as multiple infarcts predominantly located over anterior circulation. IE patients with CVE tend to have higher morbidity and mortality.
- 1 January 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (1) , e2-e3
Acquired Acrodermatitis Enteropathica
- 1 January 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (1) , e2-e3
Acquired Acrodermatitis Enteropathica
- Open Access
- 10 November 2020
- Vol. 91 (4) , e2020155
An Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19).
Coronavirus 19 disease (COVID-19) continues to be a pandemic with global implications. Respiratory system involvement is the most common manifestation in symptomatic patients. In this literature review, we describe the diagnosis, management, and implications of pulmonary hypertension (PH) among patients with COVID-19. We defined pulmonary hypertension as increasing mean pulmonary artery pressure (mPAP) of ≥ 25 mm Hg at rest. In our literature search, we identified 4 articles with details on pulmonary hypertension. Among these, two reported various echocardiographic details for diagnosing pulmonary hypertension. In 1 study evidence of pulmonary hypertension was noted in 13.4% of patients. Patients with severe COVID-19 were reported to have a higher proportion of pulmonary hypertension as compared to mild COVID-19 disease [22% vs 2%]. Elevated pulmonary artery systolic pressure was significant in predicting mortality. COVID-19 patients with chronic obstructive pulmonary disease, congestive heart failure, myocardial injury, pulmonary embolism, and prior pulmonary hypertension were at a higher risk of worsening pulmonary hypertension. Multiple mechanisms for developing pulmonary hypertension that have been postulated are i) concomitant worsening myocardial injury, ii) cytokine storm, endothelial injury, hypercoagulability attributing to development of venous thromboembolism, iii) and the presence of thrombotic microangiopathy. Among patients with severe COVID-19 disease and pulmonary hypertension, complications including acute respiratory distress syndrome, acute myocardial injury, the requirement of intensive care unit admission, the requirement of mechanical ventilation, and mortality are higher.
- 10 November 2020
- Vol. 91 (4) , e2020155
Open AccessAn Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19).
Coronavirus 19 disease (COVID-19) continues to be a pandemic with global implications. Respiratory system involvement is the most common manifestation in symptomatic patients. In this literature review, we describe the diagnosis, management, and implications of pulmonary hypertension (PH) among patients with COVID-19. We defined pulmonary hypertension as increasing mean pulmonary artery pressure (mPAP) of ≥ 25 mm Hg at rest. In our literature search, we identified 4 articles with details on pulmonary hypertension. Among these, two reported various echocardiographic details for diagnosing pulmonary hypertension. In 1 study evidence of pulmonary hypertension was noted in 13.4% of patients. Patients with severe COVID-19 were reported to have a higher proportion of pulmonary hypertension as compared to mild COVID-19 disease [22% vs 2%]. Elevated pulmonary artery systolic pressure was significant in predicting mortality. COVID-19 patients with chronic obstructive pulmonary disease, congestive heart failure, myocardial injury, pulmonary embolism, and prior pulmonary hypertension were at a higher risk of worsening pulmonary hypertension. Multiple mechanisms for developing pulmonary hypertension that have been postulated are i) concomitant worsening myocardial injury, ii) cytokine storm, endothelial injury, hypercoagulability attributing to development of venous thromboembolism, iii) and the presence of thrombotic microangiopathy. Among patients with severe COVID-19 disease and pulmonary hypertension, complications including acute respiratory distress syndrome, acute myocardial injury, the requirement of intensive care unit admission, the requirement of mechanical ventilation, and mortality are higher.
- Open Access
- 1 November 2020
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 119 (11) , 1721-1722
Mechanisms of stroke and the role of anticoagulants in COVID-19
- 1 November 2020
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 119 (11) , 1721-1722
Open AccessMechanisms of stroke and the role of anticoagulants in COVID-19
- 1 November 2020
- Published by Elsevier in Cardiovascular Pathology
- Vol. 49, 107246
Cardiovascular factors predicting poor outcome in COVID-19 patients
- 1 November 2020
- Published by Elsevier in Cardiovascular Pathology
- Vol. 49, 107246
Cardiovascular factors predicting poor outcome in COVID-19 patients
- 1 October 2020
- Published by Elsevier in World Neurosurgery
- Vol. 142, 551-552
Letter to the Editor Regarding “Acute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic: From Trough of Disillusionment to Slope of Enlightenment”
- 1 October 2020
- Published by Elsevier in World Neurosurgery
- Vol. 142, 551-552
Letter to the Editor Regarding “Acute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic: From Trough of Disillusionment to Slope of Enlightenment”
- 1 October 2020
- Published by Elsevier in World Neurosurgery
- Vol. 142, 533-534
Letter to the Editor Regarding “Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community”
- 1 October 2020
- Published by Elsevier in World Neurosurgery
- Vol. 142, 533-534
Letter to the Editor Regarding “Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community”
- Open Access
- 18 September 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (4) , 627-632
Quantifying and reporting cardiac findings in imaging of COVID-19 patients
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to be a public health emergency and a pandemic of international concern. As of April 31st, the reported cases of COVID-19 are three million in 186 countries. Reported case fatality has crossed 200 thousand among which more than fifty thousand has been in the USA. Most patients present with symptoms of fever, cough, and shortness of breath following exposure to other COVID-19 patients. Respiratory manifestations predominate in patients with mild, moderate, severe illness. Imaging of patients with COVID-19 consistently reports various pulmonary parenchymal involvement. In this article we wanted to reinforce and review the various reported imaging patterns of cardiac and mediastinal involvement in COVID-19 patients. Among patients with COVID 19 who underwent various imaging of chest various cardiac findings including pericardial effusion, myocarditis, cardiomegaly has been reported. Most of these findings have been consistently reported in patients with significant acute myocardial injury, and fulminant myocarditis. Acute biventricular dysfunction has also been reported with subsequent improvement of the same following clinical improvement. Details of cardiac MRI is rather limited. In a patient with clinical presentation of acute myocarditis, biventricular myocardial interstitial edema, diffuse biventricular hypokinesia, increased ventricular wall thickness, and severe LV dysfunction has been reported. Among patients with significant clinical improvement in LV structure and function has also been documented. With increasing number of clinical cases, future imaging studies will be instrumental in identifying the various cardiac manifestations, and their relation to clinical outcome.
- 18 September 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (4) , 627-632
Open AccessQuantifying and reporting cardiac findings in imaging of COVID-19 patients
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to be a public health emergency and a pandemic of international concern. As of April 31st, the reported cases of COVID-19 are three million in 186 countries. Reported case fatality has crossed 200 thousand among which more than fifty thousand has been in the USA. Most patients present with symptoms of fever, cough, and shortness of breath following exposure to other COVID-19 patients. Respiratory manifestations predominate in patients with mild, moderate, severe illness. Imaging of patients with COVID-19 consistently reports various pulmonary parenchymal involvement. In this article we wanted to reinforce and review the various reported imaging patterns of cardiac and mediastinal involvement in COVID-19 patients. Among patients with COVID 19 who underwent various imaging of chest various cardiac findings including pericardial effusion, myocarditis, cardiomegaly has been reported. Most of these findings have been consistently reported in patients with significant acute myocardial injury, and fulminant myocarditis. Acute biventricular dysfunction has also been reported with subsequent improvement of the same following clinical improvement. Details of cardiac MRI is rather limited. In a patient with clinical presentation of acute myocarditis, biventricular myocardial interstitial edema, diffuse biventricular hypokinesia, increased ventricular wall thickness, and severe LV dysfunction has been reported. Among patients with significant clinical improvement in LV structure and function has also been documented. With increasing number of clinical cases, future imaging studies will be instrumental in identifying the various cardiac manifestations, and their relation to clinical outcome.
- Open Access
- 27 April 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (2) , 333-336
Cerebrovascular events in COVID-19 patients
Neurological manifestations in patients with COVID–19 are more frequently being reported. Cerebrovascular events have been reported in around 3% of patients. In this review we summarize the published literature on cerebrovascular events in patients with COVID-19 as available on the PubMed database. So far, 3 studies have reported cerebrovascular events. Cerebrovascular events were identified on screening patients with decreased consciousness or in the presence of focal neurological deficits. These events were common in elderly, critically ill patients and in patients with prior cardio-cerebrovascular comorbidities. The diagnosis of cerebrovascular events was confirmed with computed tomography of the brain in most studies reporting neurological events. Multiple pathological mechanisms have been postulated regarding the process of neurological and vascular injury among which cytokine storm is shown to correlate with mortality. Patients with severe illness are found to have a higher cardio- cerebrovascular comorbidity. With an increasing number of cases and future prospective studies, the exact mechanism by which these cerebrovascular events occur and attribute to the poor outcome will be better understood.
- 27 April 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (2) , 333-336
Open AccessCerebrovascular events in COVID-19 patients
Neurological manifestations in patients with COVID–19 are more frequently being reported. Cerebrovascular events have been reported in around 3% of patients. In this review we summarize the published literature on cerebrovascular events in patients with COVID-19 as available on the PubMed database. So far, 3 studies have reported cerebrovascular events. Cerebrovascular events were identified on screening patients with decreased consciousness or in the presence of focal neurological deficits. These events were common in elderly, critically ill patients and in patients with prior cardio-cerebrovascular comorbidities. The diagnosis of cerebrovascular events was confirmed with computed tomography of the brain in most studies reporting neurological events. Multiple pathological mechanisms have been postulated regarding the process of neurological and vascular injury among which cytokine storm is shown to correlate with mortality. Patients with severe illness are found to have a higher cardio- cerebrovascular comorbidity. With an increasing number of cases and future prospective studies, the exact mechanism by which these cerebrovascular events occur and attribute to the poor outcome will be better understood.